SLC38A2 and acute myeloid leukemia: However, since the deletion of SLC38A2 only resulted in modest growth defects in AML cells (Supplementary Fig. 8h), presumably due to compensatory mechanisms among the amino acid transporters72,74, we were unable to perform the complementation analysis.